50 results
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
Assessment of Chronic Illness Therapy-Fatigue) subscale score from Week 12 to Week 24 Treatment with 100 mg mitapivat demonstrated statistically significant
8-K
EX-99.1
ys42fw7zhh8xju0
29 Jul 21
Agios Reports Business Highlights and Second Quarter 2021 Financial Results
7:17am
8-K
EX-99.2
if1g9e51p
11 Jun 21
Other Events
7:24am
8-K
EX-99.1
ejz1rckz73 n0w7h056
26 Jan 21
Other Events
4:14pm
DEFA14A
09gwcfunrybq1d4y3s
12 Jan 21
Additional proxy soliciting materials
5:15pm
DEFA14A
EX-99.2
6z2u0
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.2
n1yvly2izrgpf
21 Dec 20
Regulation FD Disclosure
7:04am
8-K
EX-99.1
bvhhhl2536fjl fdyqej
1 Dec 20
Other Events
7:46am
8-K
EX-99.3
zzvhgd
12 Jun 20
Entry into a Material Definitive Agreement
7:04am